Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors.

Saved in:
Bibliographic Details
Title: Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors.
Authors: Bach K; University of Cambridge, Department of Pharmacology, Cambridge, UK.; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Cancer Research UK, Cambridge Cancer Centre, Cambridge, UK., Pensa S; University of Cambridge, Department of Pharmacology, Cambridge, UK.; Cancer Research UK, Cambridge Cancer Centre, Cambridge, UK., Zarocsinceva M; Cancer Research UK, Cambridge Cancer Centre, Cambridge, UK.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK., Kania K; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK., Stockis J; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK., Pinaud S; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK., Lazarus KA; University of Cambridge, Department of Pharmacology, Cambridge, UK.; Cancer Research UK, Cambridge Cancer Centre, Cambridge, UK., Shehata M; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, UK., Simões BM; Manchester Breast Centre, Oglesby Cancer Research Building, University of Manchester, Manchester, UK., Greenhalgh AR; Manchester Breast Centre, Oglesby Cancer Research Building, University of Manchester, Manchester, UK., Howell SJ; Manchester Breast Centre, Oglesby Cancer Research Building, University of Manchester, Manchester, UK.; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, UK., Clarke RB; Manchester Breast Centre, Oglesby Cancer Research Building, University of Manchester, Manchester, UK., Caldas C; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK.; Cancer Research UK, Cambridge Cancer Centre, Cambridge, UK., Halim TYF; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK., Marioni JC; Cancer Research UK Cambridge Institute, Li Ka Shing Centre, University of Cambridge, Cambridge, UK. John.Marioni@cruk.cam.ac.uk.; Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK. John.Marioni@cruk.cam.ac.uk.; European Bioinformatics Institute, European Molecular Biology Laboratory, Hinxton, UK. John.Marioni@cruk.cam.ac.uk., Khaled WT; University of Cambridge, Department of Pharmacology, Cambridge, UK. wtk22@cam.ac.uk.; Cancer Research UK, Cambridge Cancer Centre, Cambridge, UK. wtk22@cam.ac.uk.; Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK. wtk22@cam.ac.uk.
Source: Nature communications [Nat Commun] 2021 Mar 09; Vol. 12 (1), pp. 1502. Date of Electronic Publication: 2021 Mar 09.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-21783-3